Dazcapistat, CAS [[2221010-42-8]]

Produktübersicht

• Artikelname: Dazcapistat, CAS [[2221010-42-8]]
• Artikelnummer: MCE-HY-132850
• Hersteller Artikelnummer: HY-132850
• Alternativnummer: MCE-HY-132850-50MG,MCE-HY-132850-100MG,MCE-HY-132850-10MMX1ML,MCE-HY-132850-10MG,MCE-HY-132850-5MG,MCE-HY-132850-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: BLD-2660

Produktbeschreibung

Dazcapistat (BLD-2660) is an orally active small-molecule inhibitor of calpain 1, 2, and 9 (calpain 1, 2, 9). Dazcapistat reduces the expression/production level of IL-6 in injured lung tissue and alleviates fibrosis. Dazcapistat exerts anti-fibrotic effects in various animal models of fibrosis in the skin, liver and lung. Dazcapistat can be used in research related to coronavirus disease 2019 (COVID-19) and idiopathic pulmonary fibrosis[1][2].

Produkteigenschaften

• Molekulargewicht: 395.38
• Reinheit: 98
• CAS Nummer: [2221010-42-8]
• Formel: C21H18FN3O4
• Target-Kategorie: Proteasome

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound